You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Human PSMA MAb Radioimmunotherapy for Prostate Cancer

    SBC: PROGENICS PHARMACEUTICALS, INC.            Topic: N/A

    Prostate cancer is the most common cancer of men in the United States with approximately 189,000 new cases and 30,000 deaths in 2002. Recurrent disease can be controlled temporarily with androgen ablation. However, almost all prostate carcinomas eventuall

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  2. Development of PSMA-based recombinant protein vaccines

    SBC: PROGENICS PHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Prostate cancer is the most common cancer of men in the United States with approximately 189,000 new cases and 30,000 deaths in 2002. Recurrent disease can be controlled temporarily with androgen ablation. However, alm

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  3. Dismounted Small Unmanned Air Vehicle (SUAV) Associate

    SBC: KUTTA TECHNOLOGIES, INC.            Topic: A03068

    In Phase I, Kutta Consulting defined and detailed its vision for a Dismounted Associate (DA) that gives America's soldiers over-the-hill battlefield intelligence. Kutta, however, did not act alone. AATD, Boeing Phantom Works, General Dynamics, Advanced Ceramics Research, Neural Robotics Incorporated, 21st Century Systems, and numerous user groups contributed significant concepts, subject matter ex ...

    SBIR Phase II 2004 Department of DefenseArmy
  4. Safe and Efficacious Oral MIF Inhibitors for Rheumatoid Arthritis

    SBC: Innovimmune Biotherapeutics Holding, LLC            Topic: NIAID

    DESCRIPTION provided by applicant There are unmet medical needs in the limited biologic therapeutics for adults with rheumatoid arthritis RA associated with $ billion annual US health care and societal costs These are due to inadequate efficacy prohibitive costs poor adherence and safety issues infections andamp malignancies Oral small molecule based therapies are warranted due to ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  5. The Potential to Immunocloak Renal Allografts

    SBC: BREONICS, INC.            Topic: NIAID

    DESCRIPTION provided by applicant The focus of this project is a novel immunomodifying therapy that provides protection from early allograft rejection in the absence of the standard toxic systemic immunosuppressive drug regimens This novel therapy is a nano barrier membrane called NB LVF consisting of a matrix made of laminin vitrogen fibronectin and type IV collagen NB LVF is applied to ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Miniaturization of Cryo-electronic All-Digital RF Systems

    SBC: HYPRES INC            Topic: A03118

    Cryogenic superconductor electronics provides unique performance capabilities in speed and accuracy of digitization and signal processing. These capabilities enable advanced software-defined communication systems which can exceed the Objective requirements of advanced systems such as the Joint Tactical Radio System (JTRS). A key component required to effectively field superconductor electronics s ...

    SBIR Phase II 2004 Department of DefenseArmy
  7. Hepatic Growth Factor Mimetic for Liver Fibrosis

    SBC: Angion Biomedica Corp.            Topic: N/A

    DESCRIPTION (provided by applicant): Hepatic fibrosis, a disease affecting tens of millions of patients worldwide, is the liver scarring response to chronic injury from viral hepatitis B or C, excessive alcohol use, iron overload or extrahepatic obstr

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  8. Linearization of HF Power Amplifiers using Direct Digital Predistortion at RF

    SBC: HYPRES INC            Topic: A03118

    Nonlinearity of RF Power Ampifiers (PAs) produces harmonic and intermodulation distortion of communication signals, significantly limiting overall system performance. This is a particular problem for multi-carrier signals in a very broadband channel, especially those spanning multiple octaves, such as HF (2-30 MHz). Conventional approaches to deal with this problem are intrinsically narrow-band ...

    SBIR Phase II 2004 Department of Defense
  9. Superconducting Technology for X-Band All Digital-RF Receiver

    SBC: HYPRES INC            Topic: A02103

    Superconducting electronics have been proven to provide unique performance enhancements in speed and accuracy of RF digitization and signal processing. These capabilities enable OBJECTIVE performance to be achieved with the Joint Tactical Radio System (JTRS), and other software-defined communication systems. Superconductor Micro-Electronics (SME) technology, with its unique combination of high pe ...

    SBIR Phase II 2004 Department of DefenseArmy
  10. Improving animal-to-human predictability in clinical trials of mental disorder

    SBC: CERTERRA, INC.            Topic: 101

    DESCRIPTION provided by applicant Huge investments in pharmaceutical research and development over the past two decades have not produced many new drugs to help treat serious neuropsychiatric diseases The increasing failure rate for new drugs at all phases of clinical trials is at least partially to blame for this productivity crisis Despite extensive precinical testing the drugs either fail ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government